[Improving the diagnostic efficacy of carcinoembryonic antigen (CEA) in gastric cancer by the simultaneous administration of Ca 72.4].
Sagredo
E
E
Soriano
A
A
Vivanco
F J
FJ
Ruibal
A
A
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D006023:Glycoproteins / Q000032:analysis*; D006801:Humans; D013274:Stomach Neoplasms / Q000032:analysis / Q000175:diagnosis* / Q000276:immunology
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen; D006023:Glycoproteins; C047052:tumor-associated antigen 72
Incremento de la eficacia diagnóstica del antígeno carcino-embrionario (CEA) en los cánceres gástricos mediante la dosificación simultánea del Ca 72.4.